NeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial
NeOnc’s (NASDAQ: NTHI) CEO purchased another 70,000 shares in the open market, bringing his recent purchases to 150,000 shares before FDA meetings
NeOnc’s (NASDAQ: NTHI) CEO purchased another 70,000 shares in the open market, bringing his recent purchases to 150,000 shares before FDA meetings